Xiaogang Li Selected Research

COVID-19

11/2021	Urinary SARS-CoV-2 RNA Is an Indicator for the Progression and Prognosis of COVID-19.
2/2021	Urinary SARS-CoV-2 RNA is An Indicator For The Progression and Prognosis of COVID-19 Disease.
2/2021	Risk factors for mortality due to COVID-19 in intensive care units: a single-center study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaogang Li Research Topics

Disease

37	Neoplasms (Cancer) 12/2023 - 07/2007
29	Autosomal Dominant Polycystic Kidney (ADPKD) 03/2024 - 03/2002
20	Cysts 01/2023 - 08/2008
14	Inflammation (Inflammations) 05/2023 - 11/2012
13	Fibrosis (Cirrhosis) 03/2024 - 01/2015
8	Hypertension (High Blood Pressure) 01/2024 - 01/2014
8	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 07/2007
6	Pancreatic Neoplasms (Pancreatic Cancer) 06/2020 - 04/2006
5	Kidney Diseases (Kidney Disease) 01/2023 - 01/2019
5	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 04/2016
5	Polycystic Kidney Diseases (Polycystic Kidney Disease) 10/2022 - 02/2003
5	Ischemic Stroke 01/2020 - 04/2014
4	Infections 05/2024 - 01/2017
4	Breast Neoplasms (Breast Cancer) 01/2023 - 09/2007
3	Wounds and Injuries (Trauma) 10/2023 - 08/2019
3	Acute Kidney Injury (Acute Renal Failure) 05/2023 - 04/2014
3	Carcinogenesis 01/2023 - 01/2018
3	Cystic Kidney Diseases (Cystic Kidney Disease) 12/2022 - 01/2021
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 01/2018
3	Stroke (Strokes) 10/2022 - 12/2019
3	Atherosclerosis 10/2022 - 12/2018
3	Diabetes Complications 01/2022 - 11/2019
3	COVID-19 11/2021 - 02/2021
3	Sepsis (Septicemia) 07/2021 - 01/2018
3	Brain Ischemia (Cerebral Ischemia) 05/2020 - 07/2013
2	Hypoxia (Hypoxemia) 05/2023 - 10/2017
2	Genomic Instability 01/2023 - 01/2022
2	Leukemia 01/2023 - 03/2017
2	Triple Negative Breast Neoplasms 12/2022 - 01/2018
2	Weight Gain 11/2022 - 11/2019
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 10/2022 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2020
2	Pathologic Constriction (Stenosis) 01/2022 - 11/2018
2	Insulin Resistance 01/2022 - 01/2013
2	Hyperglycemia 01/2022 - 01/2022
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 04/2010
2	Reperfusion Injury 01/2022 - 01/2015
2	Lymphatic Metastasis 01/2022 - 07/2007
2	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2021 - 08/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2021 - 04/2014

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2003
15	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2019
10	EnzymesIBA 02/2023 - 01/2012
9	Lysine (L-Lysine)FDA Link 03/2024 - 06/2017
6	CytokinesIBA 12/2023 - 08/2008
6	AntioxidantsIBA 02/2023 - 02/2015
6	MethyltransferasesIBA 01/2023 - 06/2017
5	MicroRNAs (MicroRNA)IBA 05/2024 - 01/2020
5	Antihypertensive Agents (Antihypertensives)IBA 01/2024 - 06/2019
5	renalaseIBA 01/2024 - 01/2014
5	Small Interfering RNA (siRNA)IBA 11/2023 - 09/2017
5	Messenger RNA (mRNA)IBA 02/2023 - 07/2013
5	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2017
5	Circular RNAIBA 01/2022 - 01/2018
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2024 - 08/2008
4	Histones (Histone)IBA 03/2024 - 01/2019
4	RNA (Ribonucleic Acid)IBA 11/2021 - 01/2015
3	Macrophage Migration-Inhibitory FactorsIBA 12/2023 - 06/2015
3	Fibronectins (Fibronectin)IBA 01/2023 - 01/2022
3	Indicators and Reagents (Reagents)IBA 01/2023 - 02/2021
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
3	NAD (NADH)IBA 01/2022 - 07/2013
3	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2018
3	Long Noncoding RNAIBA 01/2021 - 11/2017
3	Niacinamide (Nicotinamide)FDA LinkGeneric 08/2020 - 07/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2015
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2012 - 04/2010
3	Histone Deacetylase InhibitorsIBA 01/2012 - 04/2010
3	TRPP Cation ChannelsIBA 04/2010 - 03/2002
2	Irbesartan FDA LinkGeneric 01/2024 - 10/2023
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 11/2021
2	Amino Acids FDA Link 12/2023 - 11/2019
2	Polo-Like Kinase 1IBA 01/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	PeroxiredoxinsIBA 01/2023 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2023 - 01/2022
2	LigandsIBA 12/2022 - 01/2022
2	Epidermal Growth Factor (EGF)IBA 10/2022 - 09/2012
2	Rosuvastatin Calcium (Crestor)FDA Link 10/2022 - 11/2020
2	IronIBA 01/2022 - 11/2021
2	erucylphosphocholineIBA 01/2022 - 01/2018
2	ParaffinIBA 01/2022 - 01/2020
2	CollagenIBA 01/2022 - 01/2022
2	Cadherins (E-Cadherin)IBA 01/2022 - 01/2018
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 04/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021 - 11/2020
2	von Willebrand FactorIBA 11/2021 - 02/2021
2	ThrombomodulinIBA 11/2021 - 02/2021
2	Interleukin-2 (IL2)IBA 11/2021 - 01/2017
2	fibrin fragment D (D-dimer)IBA 02/2021 - 11/2019

Therapy/Procedure

17	Therapeutics 01/2024 - 12/2013
5	Punctures 12/2023 - 01/2018
3	Immunotherapy 01/2023 - 01/2021
3	Drug Therapy (Chemotherapy) 12/2020 - 10/2017
2	Enteral Nutrition (Feeding, Tube) 11/2022 - 01/2013
2	Aftercare (After-Treatment) 10/2022 - 09/2012
2	Subcutaneous Injections 11/2021 - 10/2017
2	Ligation 07/2021 - 01/2018